Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |